Navigation Links
OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
Date:11/15/2012

e to follow this patient and the others to assess the durability of response. These data validate the results from the Phase I study and effort we have put into this program, while providing further evidence of the potential role of ImmunoPulse as a safe and effective option for treating this aggressive disease."

Dr. Daud commented, "Preliminary results from this Phase II study appear to offer solid support to the earlier study indicating the efficacy of ImmunoPulse in treating metastatic melanoma. Enrollment in the study is ongoing and expected to be completed by the end of 2012. Long-term follow-up will assess durability of response."

About the Phase II ImmunoPulse Study

A total of up to 25 patients with stage III or IV cutaneous and in-transit metastatic melanoma will be enrolled in this Phase II, single-arm, open-label and multi-center study. The trial is designed to assess local and distant objective response following treatment of cutaneous melanoma lesions with DNA IL-12 and electroporation with a primary endpoint of 24 weeks. One treatment cycle will consist of three treatments applied to up to four lesions on days 1, 5 and 8 with a maximum dose of 1.5 mg DNA IL-12 per treatment cycle. At 12 months, patients will be moved to the follow-up phase of the study and will be followed for up to five years for safety.

About Melanoma

Melanoma is the most serious form of skin cancer. If it is recognized and treated early, it is almost always curable, but if it is not, the cancer can advance and spread to other parts of the body, where it becomes hard to treat and can be fatal. While it is not the most common of the skin cancers, it causes the most deaths. The American Cancer Society estimates that at present, about 123,000 new cases of melanoma in the US are diagnosed in a year, resulting in approximately 10,000 deaths. Melanoma originates in melanocytes, the cells that produce the pigment melanin that colors our skin, hair, and eyes
'/>"/>

SOURCE OncoSec Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
2. OncoSec to Present at Upcoming Healthcare and Investor Conferences
3. OncoSec Granted New Patent from China
4. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
5. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
6. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
7. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
8. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
9. OncoSec Medical Issues Letter to Shareholders
10. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
11. Patient and Disability Groups Support Bill to Begin Market Pricing System for Home Medical Equipment in Medicare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)...  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ) ("Galmed"), ... commercialization of a once-daily, oral therapy for the treatment ... it will host a conference call and webcast on ... period ended March 31, 2015 and to provide an ... program for aramchol. Conference Call & ...
(Date:5/6/2015)... GERMANTOWN, Md. , May 6, 2015 ... neural stem cell technology to develop small molecule and ... the appointment of Jonathan Lloyd Jones to ... th . Mr. Lloyd Jones ... of corporate finance and business development experience.   Most recently, ...
(Date:5/6/2015)... 6, 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ... for the three-month period ended March 31, 2015. First quarter ... million, an increase of 19% as compared to $7.0 ... Product revenues increased 41% year-over-year, enabled by the return ... Merck Serono in the fourth quarter of 2014; ...
Breaking Medicine Technology:Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 2Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 2Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 4Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 2Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 3Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 4Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 5Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 6Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 7Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 8Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 9Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 10Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results 11
... 26, 2007,/PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. , ... announced that,the two-year data from its European ... ("Vascular Wrap(TM)"),will be presented today at a ... the safety and efficacy of the Vascular,Wrap(TM) ...
... cord and other central,nervous system transplants possible, BOSTON, ... Eye Research Institute, an affiliate of Harvard Medical,School, ... into the adult central nervous system. The,study found ... induced by,stem cells) has the ability to break ...
Cached Medicine Technology:Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 2Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 3Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 4Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 5Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 6Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 7Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 2Schepens Scientists Identify Key to Integrating Transplanted Nerve,Cells Into Injured Tissue 3
(Date:5/6/2015)... Chinese technology company, Elink-IOT, has launched ... raise AUD$150,000 to finalize development of Watcher, the world’s ... watch designed to help the owner keep track of ... the item is out of range. , Using ... wearer and sends alerts on its E-paper display, and ...
(Date:5/6/2015)... The future of nursing is influenced by ... an increase in educational requirements. Leslie Brown, branch manager ... insight on these trends and how a travel nurse ... that exist in the nursing field. , Technology ... has been prevalent across the U.S. ever since the HITECH ...
(Date:5/6/2015)... York, NY (PRWEB) May 06, 2015 ... producer in New York City, announced today that it ... Creative Awards for a presentation video produced on behalf ... award in the category of motion graphics. , The ... Professionals (AMCP), received over 6000 entries from 22 countries. ...
(Date:5/6/2015)... 2015 “ Radiation Island ” was featured ... a look at the latest and coolest applications on the ... of AppWatch and technology expert, conducted the app review and ... graphic games on iOS. , Touted as one of the ... loved by users, which is obvious because of its rating ...
(Date:5/5/2015)... 06, 2015 Social Media Regulatory Affairs ... Media Your Most Powerful Marketing Tool and Get the ... http://www.fdanews.com/SocialMedia , Social media … Is it ... media’s reach. Patients are using it — learning about ... what they’ve discovered. , But, it can become a ...
Breaking Medicine News(10 mins):Health News:Crowdfunding campaign Launched for World’s First Anti-Loss Smart Watch 2Health News:National Nurses Week: Exciting Travel Nursing Trends Discussed with a Healthcare Staffing Expert 2Health News:National Nurses Week: Exciting Travel Nursing Trends Discussed with a Healthcare Staffing Expert 3Health News:National Nurses Week: Exciting Travel Nursing Trends Discussed with a Healthcare Staffing Expert 4Health News:The SGNY Group Wins Platinum Hermes Creative Award 2Health News:Top Grossing iPhone Game, Radiation Island, Was Featured on NewsWatch 2Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 2Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 3Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 4
... , KAYUNGA, Uganda, July 10 Uganda was the first ... national prevalence in HIV. The epidemic, however, remains serious as ... field have begun promoting a low cost and powerful weapon ... , Three trials in Kenya, Uganda and South Africa have ...
... Inc., the parent company of Ruth,s Chris Steak House, announced ... Street Ruth,s Chris Steak House to Tulane University for the ... a neighborhood-based medical home that will provide care to patients ... The building will honor the restaurant company,s founder, Ruth ...
... Newswise -- President Obama today announced that two Fred ... nation,s highest honor for scientists at the beginning of ... Ph.D., and cancer-prevention researcher Ulrike "Riki" Peters, Ph.D., are ... Early Career Award for Scientists and Engineers (PECASE). Each ...
... 10 Looking to reinforce its positioning as the city,s pre-eminent ... advertising campaign that speaks to New Yorkers as only a born ... "Your city. Your drugstore. Duane Reade", the campaign will ... as well as on phone kiosks, billboards and urban panels near ...
... , ... J-1/H-1B foreign physician immigration conference and job fair series announced by Pederson Immigration Law ... ... announced the details today for the 2009 J-1/H-1B Foreign Physician Immigration Conference and Job ...
... Earvin "Magic" Johnson, Chairman and Founder of the Magic ... Michaels Scholarship Program Life Skills Leadership Conference in Los ... scholarship students attending. They come from all around the ... entertain and empower. The Taylor Michaels Scholarship Program (TMSP) ...
Cached Medicine News:Health News:Ugandan Medical Male Circumcision Program Launched to Prevent HIV Transmission 2Health News:Ruth's Hospitality Group Inc. donates Broad Street building to Tulane 2Health News:Ruth's Hospitality Group Inc. donates Broad Street building to Tulane 3Health News:Two Fred Hutchinson Cancer Research Center Scientists Receive Presidential Early Career Award 2Health News:Two Fred Hutchinson Cancer Research Center Scientists Receive Presidential Early Career Award 3Health News:Two Fred Hutchinson Cancer Research Center Scientists Receive Presidential Early Career Award 4Health News:Two Fred Hutchinson Cancer Research Center Scientists Receive Presidential Early Career Award 5Health News:Duane Reade Dispenses a Large Dose of Marketing, as it Strengthens its Hometown Connection 2Health News:Duane Reade Dispenses a Large Dose of Marketing, as it Strengthens its Hometown Connection 3Health News:Pederson Immigration Law Group Announces 14th Annual J-1/H-1B Foreign Physician Immigration Conference and Job Fair Series 2Health News:Earvin 'Magic' Johnson and the Magic Johnson Foundation Give Students their 'Blueprint for Success' at Annual Leadership Conference 2
20 foot distance 22-1/2" X 11-1/2". This test for illiterate patients has HOTV letters on one side and Allen figures on the other....
McIntyre-binkhorst irrigating cannula....
Binkhorst, length 35 mm....
Army navy retractor set....
Medicine Products: